Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications | 13 | 2024 | 346 | 4.630 |
Why?
|
| Quality Improvement | 9 | 2024 | 473 | 4.590 |
Why?
|
| Breast Feeding | 6 | 2024 | 106 | 3.870 |
Why?
|
| Pregnancy | 54 | 2025 | 3110 | 3.700 |
Why?
|
| Counseling | 5 | 2024 | 171 | 3.150 |
Why?
|
| Stress, Psychological | 12 | 2020 | 329 | 3.100 |
Why?
|
| Premature Birth | 14 | 2025 | 124 | 2.840 |
Why?
|
| Peer Group | 4 | 2024 | 89 | 2.670 |
Why?
|
| Perinatal Care | 6 | 2024 | 21 | 2.540 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2024 | 84 | 2.520 |
Why?
|
| Inflammation | 9 | 2025 | 1025 | 2.510 |
Why?
|
| Placenta | 8 | 2025 | 187 | 2.490 |
Why?
|
| Pregnant Women | 5 | 2020 | 39 | 1.840 |
Why?
|
| Pregnancy Outcome | 13 | 2025 | 265 | 1.800 |
Why?
|
| Infant, Newborn | 24 | 2024 | 2517 | 1.610 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 105 | 1.570 |
Why?
|
| Cytokines | 6 | 2025 | 843 | 1.490 |
Why?
|
| Prenatal Care | 6 | 2024 | 82 | 1.440 |
Why?
|
| Pregnancy Trimester, Third | 5 | 2020 | 69 | 1.400 |
Why?
|
| Poverty | 3 | 2024 | 189 | 1.340 |
Why?
|
| Illinois | 10 | 2024 | 503 | 1.280 |
Why?
|
| Postnatal Care | 4 | 2024 | 30 | 1.260 |
Why?
|
| Cooperative Behavior | 2 | 2020 | 180 | 1.220 |
Why?
|
| Biomarkers | 10 | 2025 | 1850 | 1.220 |
Why?
|
| Female | 56 | 2025 | 47893 | 1.170 |
Why?
|
| Counselors | 2 | 2024 | 7 | 1.130 |
Why?
|
| Mothers | 3 | 2017 | 149 | 1.110 |
Why?
|
| Adult | 33 | 2025 | 27532 | 1.010 |
Why?
|
| Prospective Studies | 15 | 2024 | 4468 | 0.940 |
Why?
|
| Birth Certificates | 1 | 2023 | 8 | 0.870 |
Why?
|
| United States | 18 | 2024 | 7348 | 0.860 |
Why?
|
| Humans | 59 | 2025 | 92337 | 0.840 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 202 | 0.840 |
Why?
|
| Time-to-Treatment | 2 | 2024 | 130 | 0.830 |
Why?
|
| Gestational Age | 7 | 2021 | 327 | 0.830 |
Why?
|
| Domestic Violence | 1 | 2023 | 28 | 0.820 |
Why?
|
| Hospitals | 3 | 2023 | 314 | 0.820 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 261 | 0.810 |
Why?
|
| Hydrocortisone | 4 | 2020 | 304 | 0.800 |
Why?
|
| C-Reactive Protein | 4 | 2024 | 205 | 0.730 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2020 | 71 | 0.730 |
Why?
|
| Herpesvirus 4, Human | 2 | 2012 | 122 | 0.720 |
Why?
|
| Chorioamnionitis | 2 | 2019 | 21 | 0.710 |
Why?
|
| Perinatology | 1 | 2020 | 14 | 0.700 |
Why?
|
| Fetal Blood | 3 | 2024 | 93 | 0.700 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2018 | 498 | 0.680 |
Why?
|
| Cohort Studies | 9 | 2024 | 2978 | 0.680 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 37 | 0.650 |
Why?
|
| Medicaid | 5 | 2024 | 248 | 0.640 |
Why?
|
| Personality | 1 | 2020 | 139 | 0.610 |
Why?
|
| Depression | 2 | 2024 | 526 | 0.610 |
Why?
|
| Young Adult | 10 | 2024 | 6624 | 0.600 |
Why?
|
| Antibodies, Viral | 3 | 2018 | 302 | 0.590 |
Why?
|
| Patient Care Team | 2 | 2024 | 295 | 0.580 |
Why?
|
| Chorionic Villi | 2 | 2019 | 11 | 0.580 |
Why?
|
| Birth Weight | 6 | 2022 | 149 | 0.570 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 80 | 0.560 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 278 | 0.550 |
Why?
|
| Placental Circulation | 1 | 2016 | 11 | 0.530 |
Why?
|
| Income | 1 | 2017 | 87 | 0.530 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 162 | 0.490 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 619 | 0.490 |
Why?
|
| Obstetrics | 1 | 2017 | 123 | 0.490 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 179 | 0.490 |
Why?
|
| Social Support | 2 | 2017 | 222 | 0.490 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 709 | 0.460 |
Why?
|
| Glucocorticoids | 3 | 2021 | 367 | 0.440 |
Why?
|
| Decidua | 1 | 2012 | 19 | 0.410 |
Why?
|
| Health Promotion | 3 | 2024 | 168 | 0.410 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 444 | 0.400 |
Why?
|
| Socioeconomic Factors | 4 | 2017 | 611 | 0.400 |
Why?
|
| Racism | 3 | 2025 | 96 | 0.390 |
Why?
|
| Maternal Exposure | 4 | 2023 | 60 | 0.380 |
Why?
|
| Cesarean Section | 2 | 2024 | 148 | 0.370 |
Why?
|
| Infant, Low Birth Weight | 3 | 2022 | 60 | 0.360 |
Why?
|
| Stress, Physiological | 1 | 2012 | 245 | 0.350 |
Why?
|
| Program Evaluation | 2 | 2024 | 315 | 0.330 |
Why?
|
| Women's Health | 1 | 2010 | 105 | 0.320 |
Why?
|
| Diabetes, Gestational | 2 | 2020 | 46 | 0.320 |
Why?
|
| Principal Component Analysis | 2 | 2021 | 164 | 0.300 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2020 | 81 | 0.300 |
Why?
|
| Logistic Models | 3 | 2021 | 1239 | 0.280 |
Why?
|
| Chronic Disease | 4 | 2021 | 963 | 0.270 |
Why?
|
| Focus Groups | 2 | 2024 | 186 | 0.260 |
Why?
|
| Obesity | 4 | 2024 | 1016 | 0.230 |
Why?
|
| Glucuronidase | 1 | 2024 | 25 | 0.220 |
Why?
|
| Workflow | 1 | 2024 | 80 | 0.220 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2015 | 44 | 0.220 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 169 | 0.220 |
Why?
|
| Naloxone | 1 | 2024 | 69 | 0.220 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 43 | 0.220 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2015 | 131 | 0.220 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2023 | 10 | 0.210 |
Why?
|
| Risk Factors | 5 | 2024 | 5704 | 0.210 |
Why?
|
| Medical Records | 1 | 2023 | 122 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 172 | 0.200 |
Why?
|
| Qualitative Research | 1 | 2024 | 325 | 0.200 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 1919 | 0.200 |
Why?
|
| Patient Education as Topic | 2 | 2024 | 370 | 0.200 |
Why?
|
| Lipopolysaccharides | 2 | 2021 | 301 | 0.200 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 215 | 0.200 |
Why?
|
| Chicago | 2 | 2025 | 1466 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2024 | 800 | 0.190 |
Why?
|
| Self Report | 2 | 2015 | 307 | 0.180 |
Why?
|
| Placenta Diseases | 1 | 2021 | 13 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2020 | 168 | 0.180 |
Why?
|
| Maternal Mortality | 1 | 2021 | 15 | 0.180 |
Why?
|
| Patient Discharge | 1 | 2024 | 339 | 0.180 |
Why?
|
| Dried Blood Spot Testing | 1 | 2020 | 10 | 0.180 |
Why?
|
| Health Status Disparities | 2 | 2021 | 201 | 0.180 |
Why?
|
| Fetal Development | 2 | 2020 | 33 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2024 | 9703 | 0.180 |
Why?
|
| Infant | 4 | 2023 | 3218 | 0.180 |
Why?
|
| Mass Screening | 2 | 2023 | 675 | 0.170 |
Why?
|
| Blood Pressure | 1 | 2024 | 909 | 0.170 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2020 | 14 | 0.170 |
Why?
|
| Immunoassay | 1 | 2020 | 93 | 0.170 |
Why?
|
| Postpartum Hemorrhage | 1 | 2020 | 27 | 0.170 |
Why?
|
| Pituitary-Adrenal System | 2 | 2020 | 64 | 0.170 |
Why?
|
| Interviews as Topic | 2 | 2024 | 351 | 0.170 |
Why?
|
| Pilot Projects | 1 | 2023 | 900 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 149 | 0.170 |
Why?
|
| Adolescent | 4 | 2020 | 9504 | 0.170 |
Why?
|
| Environmental Pollution | 1 | 2019 | 13 | 0.160 |
Why?
|
| Interleukins | 1 | 2020 | 133 | 0.160 |
Why?
|
| Saliva | 2 | 2020 | 126 | 0.160 |
Why?
|
| Leukocytes | 1 | 2020 | 212 | 0.160 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 141 | 0.160 |
Why?
|
| Abortion, Spontaneous | 1 | 2019 | 67 | 0.150 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1119 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2020 | 347 | 0.150 |
Why?
|
| Health Behavior | 1 | 2020 | 185 | 0.150 |
Why?
|
| Seasons | 1 | 2019 | 241 | 0.150 |
Why?
|
| Health Equity | 1 | 2020 | 99 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2023 | 30 | 0.150 |
Why?
|
| AIDS Serodiagnosis | 1 | 2018 | 27 | 0.140 |
Why?
|
| Circadian Rhythm | 2 | 2020 | 309 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 45 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2018 | 116 | 0.140 |
Why?
|
| Psychology | 1 | 2017 | 25 | 0.140 |
Why?
|
| Parturition | 1 | 2017 | 23 | 0.140 |
Why?
|
| HIV-1 | 1 | 2018 | 161 | 0.130 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2016 | 4 | 0.130 |
Why?
|
| Residence Characteristics | 3 | 2025 | 204 | 0.130 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 5 | 0.130 |
Why?
|
| Adiposity | 1 | 2017 | 77 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 122 | 0.130 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 261 | 0.130 |
Why?
|
| Life Style | 1 | 2017 | 176 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 311 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 743 | 0.120 |
Why?
|
| Infant, Premature | 2 | 2019 | 298 | 0.110 |
Why?
|
| Phenotype | 1 | 2021 | 2498 | 0.110 |
Why?
|
| HIV Infections | 2 | 2018 | 895 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1079 | 0.110 |
Why?
|
| Age Factors | 2 | 2024 | 1905 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1774 | 0.100 |
Why?
|
| Fetal Growth Retardation | 2 | 2023 | 68 | 0.090 |
Why?
|
| Delivery, Obstetric | 2 | 2024 | 120 | 0.090 |
Why?
|
| Transcriptome | 1 | 2017 | 699 | 0.090 |
Why?
|
| Algorithms | 1 | 2019 | 1956 | 0.090 |
Why?
|
| Social Class | 2 | 2022 | 138 | 0.080 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2010 | 55 | 0.080 |
Why?
|
| Reproduction | 1 | 2010 | 201 | 0.080 |
Why?
|
| Middle Aged | 3 | 2016 | 27030 | 0.070 |
Why?
|
| Hospitals, Maternity | 1 | 2007 | 2 | 0.070 |
Why?
|
| Zidovudine | 1 | 2007 | 16 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2009 | 0.060 |
Why?
|
| Organizational Culture | 1 | 2024 | 35 | 0.060 |
Why?
|
| Twins, Dizygotic | 1 | 2024 | 42 | 0.060 |
Why?
|
| Florida | 1 | 2024 | 60 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2024 | 42 | 0.060 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2024 | 14 | 0.060 |
Why?
|
| California | 1 | 2024 | 156 | 0.060 |
Why?
|
| Fetal Death | 1 | 2024 | 57 | 0.060 |
Why?
|
| Child Abuse | 1 | 2024 | 86 | 0.050 |
Why?
|
| Overweight | 1 | 2024 | 120 | 0.050 |
Why?
|
| Child | 2 | 2024 | 7334 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 2729 | 0.050 |
Why?
|
| Police | 1 | 2022 | 25 | 0.050 |
Why?
|
| Housing | 1 | 2021 | 47 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2021 | 103 | 0.040 |
Why?
|
| Smoking | 1 | 2024 | 640 | 0.040 |
Why?
|
| Stillbirth | 1 | 2019 | 12 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 272 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1902 | 0.040 |
Why?
|
| Live Birth | 1 | 2019 | 21 | 0.040 |
Why?
|
| Hair | 1 | 2019 | 56 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 82 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 856 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 305 | 0.040 |
Why?
|
| Pandemics | 1 | 2024 | 812 | 0.040 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 46 | 0.040 |
Why?
|
| Placentation | 1 | 2017 | 11 | 0.030 |
Why?
|
| Public Health | 1 | 2018 | 145 | 0.030 |
Why?
|
| Health Policy | 1 | 2018 | 190 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1294 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2902 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2021 | 2037 | 0.030 |
Why?
|
| House Calls | 1 | 2014 | 12 | 0.030 |
Why?
|
| Psychotherapy, Group | 1 | 2014 | 35 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2794 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2004 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 5430 | 0.020 |
Why?
|
| Male | 2 | 2024 | 43925 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2007 | 286 | 0.020 |
Why?
|